Uniwersytecki Szpital Dzieciecy W Krakowie
- Address
- lock Available on a paid plan
Inflammatory Bowel Disease and Pediatric Gastroenterology
At Uniwersytecki Szpital Dzieciecy W Krakowie, research in digestive system diseases focuses strongly on ulcerative colitis and Crohn’s disease in children and teenagers. These studies are designed to assess how well new and existing treatments control inflammation, support remission, and improve long-term disease management.
- Testing biologic and oral therapies for moderate to severe ulcerative colitis and Crohn’s disease
- Evaluating long-term safety and effectiveness of maintenance treatment in pediatric inflammatory bowel disease
- Studying therapies aimed at reducing intestinal inflammation and improving clinical remission
This work reflects a major clinical focus on helping young patients with chronic gastrointestinal conditions achieve better symptom control and quality of life.
Pediatric Hematology and Leukemia
The site also has a major research presence in hemic and lymphatic diseases, especially acute lymphoblastic leukemia, acute myeloid leukemia, and lymphoblastic lymphoma. The trials are centered on improving survival, reducing relapse risk, and making treatment safer for children and adolescents.
- Evaluating new treatment strategies for acute lymphoblastic leukemia and lymphoblastic lymphoma
- Testing approaches to improve outcomes in acute myeloid leukemia, including high-risk and relapsed disease
- Exploring ways to reduce treatment-related toxicity while preserving anti-cancer effectiveness
These studies support advanced pediatric cancer care through collaborative, disease-focused research at the hospital.
Neuroblastoma and Pediatric Solid Tumors
Clinical research in neoplasms includes important work on neuroblastoma and liver tumors such as hepatoblastoma and hepatocellular carcinoma. The goal is to improve outcomes for children with aggressive or hard-to-treat cancers through better treatment combinations and more effective disease control.
- Assessing new immunotherapy and chemotherapy combinations for high-risk neuroblastoma
- Studying treatment options for recurrent or resistant neuroblastoma
- Investigating therapy strategies for pediatric liver cancers, including hepatoblastoma
These trials aim to strengthen treatment effectiveness while supporting safer care for young patients with complex solid tumors.
Kidney Disease, Anemia, and Metabolic Complications
Another key area at the Krakow pediatric hospital is nutritional and metabolic diseases and related kidney care, with studies in chronic kidney disease, anemia, proteinuric kidney disorders, and secondary hyperparathyroidism. Research here focuses on improving symptoms, correcting metabolic imbalances, and protecting kidney health in children.
- Evaluating treatments for anemia in children and adolescents with chronic kidney disease
- Studying therapies to reduce proteinuria in pediatric kidney disorders
- Assessing treatment options for secondary hyperparathyroidism in dialysis patients
This work aims to improve day-to-day health and long-term outcomes for children living with chronic renal disease.
Immune Disorders, Transplantation, and Blood Conditions
The site conducts research in immune system diseases and related inflammatory processes, including chronic graft-versus-host disease, immune thrombocytopenia, and immune support with immunoglobulin therapy. These studies are intended to refine immune-based treatment and improve safety after intensive therapies.
- Testing therapies for chronic graft-versus-host disease after transplantation
- Evaluating treatment options for chronic idiopathic thrombocytopenic purpura
- Studying immunoglobulin replacement to help prevent serious infections in children with immune deficiency
Through these investigations, the site contributes to better management of immune-related complications in pediatric care.
Rare Genetic and Metabolic Diseases
Research at Uniwersytecki Szpital Dzieciecy W Krakowie also includes congenital, hereditary, and neonatal diseases, with a focus on rare conditions such as Mucopolysaccharidosis type II and Hunter syndrome. These trials examine treatments aimed at easing disease burden and improving neurological and physical symptoms.
- Evaluating therapies for MPS II and related inherited disorders
- Studying effects on central nervous system and body-wide symptoms
- Supporting long-term care research in rare pediatric metabolic disease
This area highlights the hospital’s role in advancing care for children with uncommon, lifelong conditions.
Pediatric Transplantation and Supportive Oncology Care
The hospital participates in research on hematopoietic stem cell transplantation and related supportive care, especially for children with acute lymphoblastic leukemia. These studies are designed to improve transplant outcomes, reduce complications, and maintain the anti-leukemia benefit of treatment.
- Optimizing transplant strategies for children and adolescents with ALL
- Assessing ways to lower treatment-related toxicity after HSCT
- Exploring supportive approaches to prevent relapse and manage transplant complications
This research supports safer and more effective transplant-based care for young patients with high-risk blood cancers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 11 therapeutic areas and 15 of 102 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 101 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 20 by active trials.
lock +19 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Uniwersytecki Szpital Dzieciecy W Krakowie
lock Showing 1 of 46 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter Randomized Non‑Inferiority Trial of Weekly Somatrogon versus Daily Somatropin in Pediatric Patients with Small‑for‑Gestational‑Age or Idiopathic Short Stature | Schneider Children's Medical Center Of Israel | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 102 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Etoposide | 10 | Unknown | 2017-10-02 | 2025-12-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.